Literature DB >> 19656745

Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord.

Ana de Castro1, Marta Concheiro, Diaa M Shakleya, Marilyn A Huestis.   

Abstract

A liquid chromatography mass spectrometric selected reaction monitoring mode (SRM) method for methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), cocaine, benzoylecgonine (BE), 6-acetylmorphine, morphine and codeine quantification in human umbilical cord was developed and fully validated. Analytes were extracted from homogenized tissue (1g) by solid phase extraction. Linearity was 2.5-500ng/g, except for methadone (10-2000ng/g). Method imprecision was <12.7%CV with analytical recovery 85.9-112.7%, extraction efficiency >59.2%, matrix effect 4.5-39.5%, process efficiency 48.6-92.6% and stability >84.6%. Analysis of an umbilical cord following controlled methadone administration and illicit drug use contained in ng/g, 40.3 morphine, 3.6 codeine, 442 BE, 186 methadone and 45.9 EDDP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656745      PMCID: PMC3163088          DOI: 10.1016/j.jchromb.2009.07.028

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  29 in total

1.  Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.

Authors:  D Montgomery; C Plate; S C Alder; M Jones; J Jones; R D Christensen
Journal:  J Perinatol       Date:  2006-01-01       Impact factor: 2.521

Review 2.  Biological matrices for the evaluation of in utero exposure to drugs of abuse.

Authors:  Jaime Lozano; Oscar García-Algar; Oriol Vall; Rafael de la Torre; Giulia Scaravelli; Simona Pichini
Journal:  Ther Drug Monit       Date:  2007-12       Impact factor: 3.681

3.  Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey.

Authors:  D P Montgomery; C A Plate; M Jones; J Jones; R Rios; D K Lambert; N Schumtz; S E Wiedmeier; J Burnett; S Ail; D Brandel; G Maichuck; C A Durham; E Henry; R D Christensen
Journal:  J Perinatol       Date:  2008-07-03       Impact factor: 2.521

Review 4.  Bioanalytical procedures for monitoring in utero drug exposure.

Authors:  Teresa Gray; Marilyn Huestis
Journal:  Anal Bioanal Chem       Date:  2007-03-17       Impact factor: 4.142

5.  Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample.

Authors:  G A Richardson; S C Hamel; L Goldschmidt; N L Day
Journal:  Pediatrics       Date:  1999-08       Impact factor: 7.124

6.  Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources.

Authors:  Romaine Arlettaz; Maki Kashiwagi; Seema Das-Kundu; Jean-Claude Fauchère; Anette Lang; Hans-Ulrich Bucher
Journal:  Acta Obstet Gynecol Scand       Date:  2005-02       Impact factor: 3.636

7.  Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes.

Authors:  S L Kacinko; H E Jones; R E Johnson; R E Choo; M A Huestis
Journal:  Clin Pharmacol Ther       Date:  2008-08-13       Impact factor: 6.875

8.  Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures.

Authors:  Teresa R Gray; Raquel Magri; Diaa M Shakleya; Marilyn A Huestis
Journal:  Clin Chem       Date:  2008-10-09       Impact factor: 8.327

9.  Using population data to examine the prevalence and correlates of neonatal abstinence syndrome.

Authors:  Lucy Burns; Richard P Mattick
Journal:  Drug Alcohol Rev       Date:  2007-09

10.  The effects of prenatal cocaine use on infant development.

Authors:  Gale A Richardson; Lidush Goldschmidt; Jennifer Willford
Journal:  Neurotoxicol Teratol       Date:  2007-12-28       Impact factor: 3.763

View more
  3 in total

1.  Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.

Authors:  Ana de Castro; Hendreé E Jones; Rolley E Johnson; Teresa R Gray; Diaa M Shakleya; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-08       Impact factor: 3.681

2.  Recent Advances in Mass Spectrometry for the Identification of Neuro-chemicals and their Metabolites in Biofluids.

Authors:  Suresh Kumar Kailasa; Hui-Fen Wu
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

3.  Detection of codeine, morphine, 6-monoacetylmorphine, and meconin in human umbilical cord tissue: method validation and evidence of in utero heroin exposure.

Authors:  Joseph T Jones; Mary Jones; Brian Jones; Kristin Sulaiman; Charles Plate; Douglas Lewis
Journal:  Ther Drug Monit       Date:  2015-02       Impact factor: 3.681

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.